|
|
Volumn 9, Issue 6, 2003, Pages 569-570
|
|
Gabapentin may be appropriate for off-label uses.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID;
ACETIC ACID DERIVATIVE;
AMINE;
ANTICONVULSIVE AGENT;
CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;
GABAPENTIN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG APPROVAL;
DRUG LABELING;
ECONOMICS;
EVIDENCE BASED MEDICINE;
HUMAN;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
ACETIC ACIDS;
AMINES;
ANTICONVULSANTS;
CYCLOHEXANECARBOXYLIC ACIDS;
DRUG APPROVAL;
DRUG LABELING;
EVIDENCE-BASED MEDICINE;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 1542542006
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: 10.18553/jmcp.2003.9.6.569 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
